LAUREN BERGAMASCO: Open Payments
NPI 1912661745 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 80 payments from 21 companies in 2025. Trend: 2023 $992 · 2024 $1,493 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 13 | $229 |
| AstraZeneca Pharmaceuticals LP | 11 | $199 |
| GlaxoSmithKline, LLC. | 9 | $180 |
| Daiichi Sankyo Inc. | 9 | $165 |
| Janssen Biotech, Inc. | 6 | $105 |
| EMD Serono, Inc. | 5 | $82 |
| Eisai Inc. | 4 | $68 |
| Agios Pharmaceuticals, Inc. | 3 | $53 |
| Davol Inc. | 1 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
Products named: ENHERTU, LYNPARZA, KEYTRUDA, JEMPERLI, TALVEY, Lenvima, PYRUKYND, ARISTA.
Industry payments across NJ — which companies pay providers there.
